Centre for Commercialization of Regenerative Medicine (CCRM)
The Centre for Commercialization of Regenerative Medicine (CCRM) is a Canadian not-for-profit, public-private consortium funded by the Government of Canada’s Networks of Centres of Excellence program, seven Canadian institutional partners and more than 45 companies representing the key sectors of the regenerative medicine industry. CCRM, a Centre of Excellence for Commercialization and Research (CECR), supports the development of technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies.
CCRM is co-led by Chief Scientific Officer Dr. Peter Zandstra, Canada Research Chair in Stem Cell Bioengineering and the recipient of a number of prestigious awards, and President and CEO Dr. Michael May – a University of Toronto alumnus. CCRM sources and conducts diligence on intellectual property from around the globe, performing fee-for-service and development projects with academia and industry in the areas of cell reprogramming and engineering, cell manufacturing and biomaterials. CCRM has a fully resourced, 6,000 square foot development facility, located at the Banting Institute at the University of Toronto, used to advance technologies for out-licensing or company creation.
A network of academics, industry and entrepreneurs, CCRM translates scientific discoveries into marketable products for patients. CCRM launched in Toronto’s Discovery District on June 14, 2011.
CCRM’s Mission
To create and sustain a global nexus for regenerative medicine (RM) translation and commercialization by unifying dynamic business leadership, academic discovery and strategic investment around dedicated translational platforms based on demonstrated excellence in stem cell science and bioengineering.
CCRM’s Vision is to be a commercialization network that is a:
Premier destination for risk capital, leading industry, intellectual property, clinical trials and the best people in RM;
Rich and vibrant industry community, composed of new start-ups and established RM companies;
Portfolio of investments in RM companies and technologies licensed to industry that generate enough revenue to achieve sustainability;
Global RM patent house, through international intellectual property (IP) sourcing and in-house technology development;
Dynamic and exciting environment in which to build a career in RM at the interface between academia and industry.
You can also watch CCRM’s video Leadership Series, which includes some familiar University of Toronto faces, and Innovation Series on its RM Video Network.
